| Predicate |
Object |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-484
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-258
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-725 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-258
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-484
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-22 |
| filingDate |
2007-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2013-04-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate |
2013-04-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-101256210-B1 |
| titleOfInvention |
Pharmaceutical composition for the treatment of anxiety |
| abstract |
Provided are pharmaceutical compositions and functional foods for the treatment of anxiety disorders containing ginseng saponin (Rg1 + Rb1), glycyrrhizic acid and jujuba cAMP. Experimental examples are described in comparison with diazepam, which is a conventional preferred therapeutic agent for anxiety disorders. The present invention has significant antidepressant and anti-anxiety action. |
| priorityDate |
2007-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |